Amgen Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other
companies in this sector in the United States:
sales of $4.92 billion
of which 79%
Gilead Sciences, Inc.
of which 89%
was Antiviral products), and
of which 100%
was Novel Therapeutics).
Amgen Inc. reported sales of $22.85 billion
December of 2017.
decrease of 0.6%
versus 2016, when the company's sales were $22.99 billion.